These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2759546

  • 1. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT, Lee FY, Lin HC, Chang TT, Lay CS, Wang SS, Kong CW, Lee SD, Lo KJ.
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [Abstract] [Full Text] [Related]

  • 2. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 3. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD, Plevris JN, Redhead DN, Bouchier IA, Hayes PC.
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodés J.
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions.
    Blei AT, Garcia-Tsao G, Groszmann RJ, Kahrilas P, Ganger D, Morse S, Fung HL.
    Gastroenterology; 1987 Sep; 93(3):576-83. PubMed ID: 3301517
    [Abstract] [Full Text] [Related]

  • 6. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P, Hallemans R, Melot C, Lejeune P, Naeije R.
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [Abstract] [Full Text] [Related]

  • 7. Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.
    Jones AL, Bangash IH, Walker J, Simpson KJ, Finlayson ND, Hayes PC.
    Gut; 1995 Jan; 36(1):104-9. PubMed ID: 7890211
    [Abstract] [Full Text] [Related]

  • 8. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC, Feu F, Navasa M, Bru C, Ruiz del Arbol L, Bosch J, Rodés J.
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [Abstract] [Full Text] [Related]

  • 9. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 10. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M, Chesta J, Bosch J, Rodés J.
    Gastroenterology; 1989 Apr 15; 96(4):1110-8. PubMed ID: 2925055
    [Abstract] [Full Text] [Related]

  • 11. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD.
    Am J Gastroenterol; 2004 Oct 15; 99(10):1953-8. PubMed ID: 15447755
    [Abstract] [Full Text] [Related]

  • 12. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
    Silva G, Segovia R, Ponce R, Backhouse C, Palma M, Roblero JP, Abadal J, Quijada C, Troncoso M, Iturriaga H.
    Hepatogastroenterology; 2002 Oct 15; 49(47):1357-62. PubMed ID: 12239942
    [Abstract] [Full Text] [Related]

  • 13. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M, Toyonaga A, Tanikawa K.
    Am J Gastroenterol; 1992 Sep 15; 87(9):1160-4. PubMed ID: 1519573
    [Abstract] [Full Text] [Related]

  • 14. Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
    Piscaglia F, Donati G, Gaiani S, Gramantieri L, Leoni S, Mancini M, Bolondi L.
    Dig Liver Dis; 2004 Sep 15; 36(9):594-602. PubMed ID: 15460844
    [Abstract] [Full Text] [Related]

  • 15. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
    Bellis L, Berzigotti A, Abraldes JG, Moitinho E, García-Pagán JC, Bosch J, Rodés J.
    Hepatology; 2003 Feb 15; 37(2):378-84. PubMed ID: 12540788
    [Abstract] [Full Text] [Related]

  • 16. Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
    Merkel C, Sacerdoti D, Bolognesi M, Buonamico P, Sticca A, Amodio P, Angeli P, Micotti L, Gatta A.
    Eur J Gastroenterol Hepatol; 1999 Nov 15; 11(11):1221-5. PubMed ID: 10563530
    [Abstract] [Full Text] [Related]

  • 17. Lack of effects of nifedipine on hepatic hemodynamics in patients with HBsAg-positive cirrhosis.
    Lay CS, Tsai YT, Kong CW, Lee FY, Lee SD, Lo KJ, Chiang BN, Chen KY.
    Liver; 1987 Aug 15; 7(4):223-7. PubMed ID: 3683094
    [Abstract] [Full Text] [Related]

  • 18. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC, Westaby D, Williams R.
    Gut; 1988 Jun 15; 29(6):752-5. PubMed ID: 3384359
    [Abstract] [Full Text] [Related]

  • 19. Effect of peroral administration of isosorbide dinitrate on portal pressure and blood flow in patients with cirrhosis of the liver.
    Cervinka J, Kordac V, Kalab M.
    J Int Med Res; 1989 Jun 15; 17(6):560-4. PubMed ID: 2628133
    [Abstract] [Full Text] [Related]

  • 20. Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation.
    Forrest EH, Jalan R, Redhead DN, Hayes PC.
    Aliment Pharmacol Ther; 1996 Oct 15; 10(5):795-800. PubMed ID: 8899089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.